Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Insight into the mechanism of action of ATI-5261, a novel synthetic peptide

Nov. 20, 2009

Chymase inhibitor improves left ventricular function after mitral regurgitation

Nov. 20, 2009

VALIANT study results suggest increased HR is predictive of worse outcome in post-MI

Nov. 20, 2009

TB-403 shown to be safe in healthy males and cancer patients in phase I trials

Nov. 20, 2009

Interim clinical data reported for SCH-900518 combination regimens

Nov. 20, 2009

Pioglitazone slows atherosclerosis progression in type 2 diabetes patients

Nov. 19, 2009

Favorable safety and lipid profiles with anacetrapib therapy in hyperlipidemia

Nov. 19, 2009

E-3810 exhibits potent antiangiogenic activity in preclinical studies

Nov. 19, 2009

CH-5137291evaluated in preclinical models of castration-resistant prostate cancer

Nov. 19, 2009

Phase I data on JNJ-26483327 in solid tumors reported at 2009 AACR-NCI-EORTC meeting

Nov. 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...